Page last updated: 2024-09-04
mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and cypermethrin
mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with cypermethrin in 1 studies
Compound Research Comparison
| Studies (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Trials (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Recent Studies (post-2010) (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Studies (cypermethrin) | Trials (cypermethrin) | Recent Studies (post-2010) (cypermethrin) |
|---|---|---|---|---|---|
| 69 | 0 | 42 | 1,697 | 33 | 916 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Agrawal, S; Dixit, A; Patel, DK; Singh, A; Singh, D; Singh, MP; Tripathi, P | 1 |
Other Studies
1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and cypermethrin
| Article | Year |
|---|---|
Cyclosporine A and MnTMPyP Alleviate α-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism.
Topics: alpha-Synuclein; Animals; Corpus Striatum; Cyclosporine; Dopaminergic Neurons; Metalloporphyrins; Mitochondria; Oxidative Stress; Parkinson Disease; Parkinsonian Disorders; Pyrethrins; Rats, Wistar; Substantia Nigra | 2015 |